IndraLab

Statements

TAT binds CACNA1B, DEFB103A, DPYSL2, and STR1. 1 / 1

| 1

sparser

"We have demonstrated that interfering with the CaV2.2–CRMP2 interaction with TAT-conjugated CBD3-scaffold peptides ST1-104, ST1-106, and ST1-107 mitigates inflammatory and neuropathic pain ( xref , xref , xref , xref )."

23106100

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

TAT binds CACNA1B, DEFB103A, DPYSL2, and STR1. 1 / 1

INDRA sources:

Databases

Reading